Bio-pharma logistics involves the transportation of temperature-sensitive biologics and pharmaceuticals using temperature-controlled packaging and shipping methods under stringent protocols. The pharmaceutical products that require bio-pharma logistics include vaccines, injectable drugs, drugs requiring controlled temperatures, DNA/RNA material, blood products, and more. Cold chain logistics plays a vital role in ensuring the quality and efficacy of such products during transport. The global bio-pharma logistics market allows for more efficient management of inventory as well as reliable, on-time delivery of medications and helps reduce wastage.
The global bio-pharma logistics market is estimated to be valued at US$ 100.2 Bn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The growing demand for cold chain logistics from the pharmaceutical industry is expected to drive the growth of the bio-pharma logistics market over the forecast period. Strict regulations regarding the transportation and storage of temperature-sensitive drugs and biologics necessitate reliability in cold chain logistics. Moreover, the increasing complexity of supply chains for pharmaceutical products has boosted requirement for specialized logistics services with real-time tracking and improved quality control. However, high setup and operational costs associated with maintaining the cold chain pose a challenging barrier.
SWOT Analysis
Strength: The bio-pharma logistics market benefits from stringent regulations surrounding temperature-controlled transportation and storage of pharmaceutical products. Ensuring product quality and safety is a top priority, driving demand for reliable logistics solutions. Furthermore, the growing biologics and cell and gene therapy sectors require specialized handling and monitoring, playing to the strengths of experienced bio-pharma logistics providers.
Weakness: Maintaining chilled or frozen conditions throughout the supply chain poses technical challenges and increases costs. Unpredictable delays can cause temperature excursions, compromising product integrity. Securing qualified personnel and ensuring compliance with ever-evolving regulations also present ongoing hurdles.
Opportunity: The market is witnessing increased outsourcing of temperature-controlled transport and warehousing as biopharma firms seek to optimize resources. Expanding access to healthcare in developing nations opens new opportunities for demand. Rapid growth of online pharmacies and direct-to-patient distribution models likewise necessitate optimized specialty logistics support.
Threats: Consolidation across the logistics industry could disadvantage some players. Political and economic instability in certain regions poses risks to Infrastructure and operations. Rising fuel costs and supply chain disruptions also threaten profit margins. Intensifying competition to win contracts compresses pricing.
Key Takeaways
The Global Bio-Pharma Logistics Market Size is expected to witness high growth over the forecast period. The market size is projected to increase from US$ 100.2 billion in 2023 to over US$ 180 billion by 2030, registering a CAGR of around 8.5%.
Regional analysis
North America currently dominates the global market, supported by substantial biopharma R&D spending and advances in specialized therapies. The US and Canada are home to leading biologics producers as well as major logistics firms, reinforcing regional dominance. However, Asia Pacific is poised to exhibit the fastest growth through 2030. Increased pharmaceutical manufacturing and improving connectivity throughout India, China, and other Asian countries are expanding demand.
Key players
Key players operating in the bio-pharma logistics market are DHL, FedEx, UPS, DB Schenker, Kuehne + Nagel, SF Express, Kerry Logistics, Agility Logistics, VersaCold Logistics Services, Marken, Air Canada Cargo, CEVA Logistics, Sofrigam, Nordic Cold Storage, Biocair, United Parcel Service, Cavalier Logistics, LifeConEx, AirBridgeCargo Airlines, and World Courier. The market demonstrates high consolidation as robust capabilities and compliance expertise are required to reliably support temperature-controlled biologics distribution worldwide.
Get More Insights Here
https://www.trendingwebwire.com/bio-pharma-logistics-market-size-share-growth-outlook-2023/
In this report, global Bio Pharma Buffer Market will reach 929.47 Million USD by the end of 2022 with a CAGR of 7.81% The global Bio Pharma Buffer market was valued at 638.29 Million USD in 2017 and will reach 929.47 Million USD by the end of 2022, growing at a CAGR of 7.81% during 2017-2022.
Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH.
Download Free Sample Report @ https://www.radiantinsights.com/research/global-bio-pharma-buffer-market-2020-2026/request-sample Bio Pharma Buffer can be divided into four categories: Phosphates Type, Acetates Type and TRIS Type.
Phosphates Type accounted for the highest proportion in revenue market, with a figure of 28.68% in 2017, followed by TRIS Type, account for 22.65% and Acetates Type account for 13.33%.
The sales market share of global Bio Pharma Buffer in Research Institution use, \Pharmaceutical Industry use and other applictions have been stable year by year, at 42.10%, 50.48% and 7.42% respectively in 2017, and for several consecutive years, the amplitude was within one percent.
This indicates that the segment of the Bio Pharma Buffer in the global market tends to be fixed without great changes.
The aim of this report Bio-pharma Market, This report provides over view of manufacturers, production, application and regions.
The report show the regions wise production, revenue, consumption, import and export in these regions.Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Bio-pharma for these regions, from 2012 to 2023 (forecast), coveringChinaUSAEuropeJapanKoreaIndiaGlobal Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including PfizerF.
Hoffmann-La Roche AGJohnson & Johnson ServicesSanofi, AmgenAbbVieMerck & Co., IncBiogen IdecBayer AGEli Lilly and CompanyNovartis AG GlaxoSmithKline PlcBristol-Myers Squibb CompanyAstraZeneca PLCAbbott Laboratories Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-biopharma-2018-436/?utm_source=techsite_Vinodkumar Manik Pawar_medium=ReferralOn the basis of product, Bio-pharma Market displays the production, revenue, price, market share and growth rate of each type, primarily split intoMonoclonal AntibodiesRecombinant ProteinsGranulocyte-Colony Stimulating Factor (G-CSF)InterferonsRecombinant Human InsulinErythropoietinVaccinesGrowth HormonesPurified ProteinsOthersOn the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Bio-pharma for each application, includingMetabolic DisordersOncologyNeurological DisordersCardiovascular DiseasesInflammatory and Infectious DiseasesOthersIf you have any special requirements, please let us know and we will offer you the report as you want.Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-biopharma-2018-436/?utm_source=techsite_Vinodkumar Manik Pawar_medium=ReferralCONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/24-market-reports
The statistical surveying report on the global Bio Pharma Buffer Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.
The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.
The statistical data derived from authentic resources and assisted by industry experts.
It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.The global Bio Pharma Buffer market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels.
For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.Get FREE Sample Report Copy @ https://www.decisiondatabases.com/contact/download-sample-43044According to this study, over the next five years, the Bio Pharma Buffer market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 920 million by 2025, from US$ 680 million in 2020.
